University General Hospital of Patras

Pátrai, Achaia 26504

1 studies enrolling now · 7 studies all time

What they study most

Chronic Anemia, Crohn's Disease, Ineffective Erythropoiesis, Primary Immune Thrombocytopenia, Relapsed and/or Refractory Multiple Myeloma, Relapsed or Refractory Systemic Light Chain Amyloidosis, Ulcerative Colitis, Waldenström's Macroglobulinemia, β-thalassemia

Studies at this site

• A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Crohn's Disease — Recruiting now
• A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Ulcerative Colitis — Running, not enrolling
• Study of Dexamethasone Plus IXAZOMIB (MLN9708) or Physicians Choice of Treatment in Relapsed or Refractory Systemic Light Chain (AL) Amyloidosis — Stopped early
• A Study of TAK-079 in Adults With Persistent/Chronic Primary Immune Thrombocytopenia — Completed
• A Study of Ixazomib, Given With Dexamethasone in Adults With Multiple Myeloma — Completed
• Study of PTG-300 in Non-Transfusion Dependent and Transfusion-Dependent Beta-Thalassemia Subjects With Chronic Anemia — Completed
• Ibrutinib With Rituximab in Adults With Waldenström's Macroglobulinemia — Completed